Literature DB >> 22260164

Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trials.

H Miles Prince1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22260164     DOI： 10.3109/10428194.2012.658571

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  Epigenetic modulating agents as a new therapeutic approach in multiple myeloma.

Authors:  Ken Maes; Eline Menu; Els Van Valckenborgh; Ivan Van Riet; Karin Vanderkerken; Elke De Bruyne
Journal:  Cancers (Basel)       Date:  2013-04-15       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.